Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy N C Wells

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Malaria Journal|March 18, 2011
Natural products as starting points for future anti-malarial therapies: going back to our roots?Timothy N C Wells
Infectious Disorders Drug Targets|December 6, 2013
Discovering and developing new medicines for malaria control and eliminationTimothy N C Wells
Nature Reviews. Drug Discovery|July 18, 2002
New therapeutics that modulate chemokine networksMatthias K Schwarz, Timothy N C Wells
Current Topics in Medicinal Chemistry|March 16, 2011
The state of the art in anti-malarial drug discovery and developmentJeremy N Burrows, Kelly Chibale, Timothy N C Wells
Malaria Journal|August 24, 2012
A framework for assessing the risk of resistance for anti-malarials in developmentXavier C Ding, David Ubben, Timothy N C Wells
Nature Reviews. Drug Discovery|February 25, 2017
Managing intellectual property to develop medicines for the world's poorestSylvie Fonteilles-Drabek, David Reddy, Timothy N C Wells
Trends in Parasitology|February 6, 2010
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria eliminationTimothy N C Wells, Jeremy N Burrows, J Kevin Baird
Nature Reviews. Drug Discovery|October 17, 2009
New medicines to improve control and contribute to the eradication of malariaTimothy N C Wells, Pedro L Alonso, Winston E Gutteridge
Nature Reviews. Drug Discovery|May 23, 2015
Malaria medicines: a glass half full?Timothy N C Wells, Rob Hooft van Huijsduijnen, Wesley C Van Voorhis
Thrombosis and Haemostasis|May 15, 2002
Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVIDu Xiao-Yan, Edith Magnenat, Timothy N C Wells, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Malaria Journal|March 18, 2011
Natural products as starting points for future anti-malarial therapies: going back to our roots?Timothy N C Wells
Infectious Disorders Drug Targets|December 6, 2013
Discovering and developing new medicines for malaria control and eliminationTimothy N C Wells
Nature Reviews. Drug Discovery|July 18, 2002
New therapeutics that modulate chemokine networksMatthias K Schwarz, Timothy N C Wells
Current Topics in Medicinal Chemistry|March 16, 2011
The state of the art in anti-malarial drug discovery and developmentJeremy N Burrows, Kelly Chibale, Timothy N C Wells
Malaria Journal|August 24, 2012
A framework for assessing the risk of resistance for anti-malarials in developmentXavier C Ding, David Ubben, Timothy N C Wells
Nature Reviews. Drug Discovery|February 25, 2017
Managing intellectual property to develop medicines for the world's poorestSylvie Fonteilles-Drabek, David Reddy, Timothy N C Wells
Trends in Parasitology|February 6, 2010
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria eliminationTimothy N C Wells, Jeremy N Burrows, J Kevin Baird
Nature Reviews. Drug Discovery|October 17, 2009
New medicines to improve control and contribute to the eradication of malariaTimothy N C Wells, Pedro L Alonso, Winston E Gutteridge
Nature Reviews. Drug Discovery|May 23, 2015
Malaria medicines: a glass half full?Timothy N C Wells, Rob Hooft van Huijsduijnen, Wesley C Van Voorhis
Thrombosis and Haemostasis|May 15, 2002
Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVIDu Xiao-Yan, Edith Magnenat, Timothy N C Wells, et al.
Pageof 7